The DOI matches its Crossref record, with a small difference in title or year; 94 of the 96 references it cites were found in a registry or an index; none of the 71 sources its claims cite is checked for support yet.
Obesity and Cardiovascular Disease
Open accessAbstract
Obesity has reached global epidemic proportions in both adults and children and is associated with numerous comorbidities, including hypertension (HTN), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing, certain cancers, and major cardiovascular (CV) diseases. Because of its maladaptive effects on various CV risk factors and its adverse effects on CV structure and function, obesity has a major impact on CV diseases, such as heart failure (HF), coronary heart disease (CHD), sudden cardiac death, and atrial fibrillation, and is associated with reduced overall survival. Despite this adverse association, numerous studies have documented an obesity paradox in which overweight and obese people with established CV disease, including HTN, HF, CHD, and peripheral arterial disease, have a better prognosis compared with nonoverweight/nonobese patients. This review summarizes the adverse effects of obesity on CV disease risk factors and its role in the pathogenesis of various CV diseases, reviews the obesity paradox and potential explanations for these puzzling data, and concludes with a discussion regarding the current state of weight reduction in the prevention and treatment of CV diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 71 cited sources checked · 0 supported · 0 flagged
In the paper
“In a study of 530 patients, we noted marked improvements in CHD risk factors among overweight and obese CHD patients who lost weight, including CRP, lipids, and glucose, and this group had a trend of lower mortality (48).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [48] Lavie, 2009, The obesity paradox, weight loss, and coronary disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a small subgroup of 45 obese patients with 5% or more weight loss (average 10%) after cardiac rehabilitation, we noted more significant improvements in exercise capacity and plasma lipids than in 81 obese patients who did not lose weight (76).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [76] Lavie, 1997, Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a study of 530 patients, we noted marked improvements in CHD risk factors among overweight and obese CHD patients who lost weight, including CRP, lipids, and glucose, and this group had a trend of lower mortality (48).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [48] Lavie, 2009, The obesity paradox, weight loss, and coronary disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a study of 5,881 Framingham Heart Study participants, Kenchaiah et al. (30) showed that during a 14-year follow-up, for every 1 kg/m 2 increment in BMI, the risk of HF increased 5% in men and 7% in women.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [30] Kenchaiah, 2002, Obesity and the risk of heart failure, N Engl J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“These abnormalities not only increase the risk of HF, but LA enlargement may increase the risk of AF and its morbid complications discussed later (20).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [20] Wang, 2004, Obesity and the risk of new-onset atrial fibrillation, JAMA source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In contrast, however, other studies assessing mortality based on body fat and lean mass rather than BMI or weight alone have suggested that subjects losing body fat rather than lean mass have a lower mortality (67,69).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“During 2-year follow up, all-cause mortality was 30% lower in overweight and obese patients, despite less effective blood pressure control in these patients compared with the normal weight group.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [25] Uretsky, 2007, Obesity paradox in patients with hypertension and coronary artery disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In addition to LV structural abnormalities, obesity also leads to left atrial (LA) enlargement, both from increased circulating blood volume as well as abnormal LV diastolic filling (14,19).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Even independent of arterial pressure and age, obesity increases the risk of left ventricular hypertrophy (LVH), as well as other structural abnormalities, including concentric remodeling (CR) and concentric LVH (18).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [18] Lavie, 2007, Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Despite this adverse association, numerous studies have documented an obesity paradox in which overweight and obese people with established CV disease, including HTN, HF, CHD, and peripheral arterial disease, have a better prognosis compared with nonoverweight/ nonobese patients.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 26
- Probably not a substantial claim. 2
- The quote only partly states this claim. 2
In the paper
“Recently, we noted marked reductions after cardiac rehabilitation in CRP levels in obese CHD patients, whereas lean patients had only slight and nonsignificant declines in CRP (77).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [77] Lavie, 2008, Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients, J Cardiometab Syndr source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Considering that some long-term studies have shown that weight loss in overweight and obesity is associated with increased mortality coupled with many CV studies showing a better prognosis with a higher BMI, it has been suggested that purposeful weight loss may not be beneficial and may even be detrimental in patients with CV diseases (31,66 -68).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [31] Horwich, 2001, The relationship between obesity and mortality in patients with heart failure, J Am Coll Cardiol source
- Not checked yetcites [66] Fonarow, 2002, Obesity, weight reduction and survival in heart failure: reply, J Am Coll Cardiol source
- Not checked yetcites [67] Allison, 1999, Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies, Int J Obes Relat Metab Disord source
- Not checked yetcites [68] Sierra-Johnson, 2008, Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index, Eur Cardiovasc Prev Rehabil source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The adipocyte acts as an endocrine organ, and plays a substantial role in the pathogenesis and complications of obesity (1,10).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent evidence indicates that obesity is associated with more morbidity than smoking, alcoholism, and poverty, and if current trends continue, obesity may soon overtake cigarette abuse as the leading cause of preventable death in the U.S. (6 -8).”
What the sources say
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
- Not checked yetcites [7] Manson, 2003, Obesity in the United States: a fresh look at its high toll, JAMA source
- Not checked yetcites [8] Sturm, 2001, Does obesity contribute as much to morbidity as poverty or smoking?, Public Health source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In fact, OSA may contribute to the pathogenesis of HTN and increased inflammation and CRP (61).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > -Hippocrates (54)
What the sources say
- Not checked yetcites [61] Shamsuzzaman, 2002, Elevated C-reactive protein in patients with obstructive sleep apnea, Circulation source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“with the prevalence among adults increasing by nearly 50% during the 1980s and 1990s (5); now, nearly 70% of adults are classified as overweight or obese compared with fewer than 25% 40 years ago (5)(6)(7).”
What the sources say
- Not checked yetcites [5] Flegal, 2002, Prevalence and trends in obesity among US adults, 1999–2000, JAMA source
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
- Not checked yetcites [7] Manson, 2003, Obesity in the United States: a fresh look at its high toll, JAMA source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Obesity is a classic cause of alveolar hypoventilation and the obstructive sleep apnea (OSA) syndrome (60).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > -Hippocrates (54)
What the sources say
- Not checked yetcites [60] Trollo, 1996, Obstructive sleep apnea, N Engl J Med source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“We have also documented the inverse relationship between BMI and all-cause mortality in over 30,000 patients with preserved LV systolic function referred for echocardiography (18).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [18] Lavie, 2007, Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because of its maladaptive effects on various CV risk factors and its adverse effects on CV structure and function, obesity has a major impact on CV diseases, such as heart failure (HF), coronary heart disease (CHD), sudden cardiac death, and atrial fibrillation, and is associated with reduced overall survival.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, in patients with a BMI Ն35 kg/m 2 , there was an excess risk for CV mortality without any increase in total mortality.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [47] Romero-Corral, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Obesity has reached global epidemic proportions in both adults and children and is associated with numerous comorbidities, including hypertension (HTN), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing, certain cancers, and major cardiovascular (CV) diseases.”
What the sources say
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Typically, obese patients have a higher cardiac output but a lower level of total peripheral resistance at any given level of arterial pressure (14,15).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In the subgroup of 5 population-based studies enrolling 78,602 patients, obese patients had a nearly 50% increased risk of developing AF that escalated with increasing BMI.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [52] Wanahita, 2008, Atrial fibrillation and obesity—results of a meta-analysis, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Likewise, in an analysis of BMI and in-hospital mortality for 108,927 decompensated HF patients, higher BMI was associated with lower mortality (35).”
- Also stated in: § Clinical Consequences of Obesity · plain
“In fact, for every 5-unit increase in BMI, the risk of mortality was 10% lower (p Ͻ 0.001).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [35] Fonarow, 2007, An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Clinical Consequences of Obesity · plain
In the paper
“A recent study of nearly 360,000 participants from 9 European countries showed that both general obesity and abdominal adiposity are associated with risk of death and support the importance of WC or WHR in addition to BMI for assessing mortality risk (4).”
What the sources say
- Not checked yetcites [4] Pischon, 2008, General and abdominal adiposity and risk of death in Europe, N Engl J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Certainly, starvation, very-low-calorie diets, liquid protein diets, and obesity surgeries have been associated with prolongation of the QTc interval and increased risk of malignant dysrhythmias (1), and various pharmacologic agents have either limited efficacy or considerable toxicity (70 -72).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [1] Poirier, 2006, Circulation source
- Not checked yetcites [70] Connolly, 1997, Valvular heart disease associated with fenfluramine-phentermine, N Engl J Med source
- Not checked yetcites [71] Albenhaim, 1996, Appetite-suppressant drugs and the risk of primary pulmonary hypertension, N Engl J Med source
- Not checked yetcites [72] Zannad, 2002, Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Obesity increases total blood volume and cardiac output, and cardiac workload is greater in obesity.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [14] Alpert, 2001, Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome, Am J Med Sci source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This study also showed a powerful obesity paradox, with progressive reductions in mortality in normal BMI, overweight, and obese groups compared with underweight patients.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [50] Galal, 2009, The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease, Chest source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
None of the sources cited for this claim have been checked yet.
In the paper
“In fact, for each 1-U increase in BMI, there was an increase of 4% in the risk of ischemic stroke and 6% for hemorrhagic stroke (1,53).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Obesity and stroke.
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In a multivariate model, leptin was an independent predictor of CV events, whereas CRP was not.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Recently, increased concentrations of both CRP and leptin were associated with an increased risk of major CV events, but leptin seems to be a more robust predictor (13).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
What the sources say
- Not checked yetcites [13] Romero-Corral, 2008, Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population, Nat Clin Pract Cardiovasc Med source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“a recent small study suggests that bariatric surgery is safe and effective in patients with severe systolic HF (87).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [87] Ramani, 2008, Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure, Clin Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In HF, despite the obesity paradox, trials have suggested that weight loss can induce improvements in LV mass as well as in systolic and diastolic ventricular function (14).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [14] Alpert, 2001, Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome, Am J Med Sci source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Although 30-day mortality after gastric bypass has recently been reported to be higher than expected, closely linked to surgeon inexperience (80)”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [80] Flum, 2004, Impact of gastric bypass operation on survival: a population-based analysis, J Am Coll Surg source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Weight loss also was associated with marked improvements in LV chamber size, LV end-systolic wall stress, and systolic and diastolic LV function.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [23] Alpert, 1997, Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These studies support purposeful weight reduction in overweight and obese CHD patients, despite the obesity paradox.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“more studies are now showing that these surgical procedures are associated with short-and long-term improvements in major morbidity and all-cause mortality, particularly related with cancers, DM, and CV diseases”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [81] Adams, 2007, Long-term mortality after gastric bypass surgery, N Engl J Med source
- Not checked yetcites [82] Sjöström, 2007, Effects of bariatric surgery on mortality in Swedish obese subjects, N Engl J Med source
- Not checked yetcites [83] Christou, 2004, Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients, Ann Surg source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further weight reduction cannot be considered protective against CVD.366 -369”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
In the citing paper
“If, at the population level, obesity is associated with an increased risk of CVD incidence and mortality, among those with established coronary artery disease, the evidence is contradictory.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
In the citing paper
“Systematic reviews of patients with coronary artery disease or undergoing PCI have suggested an 'obesity paradox' whereby obesity appears protective against an adverse prognosis.366 -369”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Clearly lifestyle interventions, including exercise training and at least mild weight reduction with caloric restriction, showed a nearly 60% reduction in the risk of developing DM, which was considerably better than that noted in patients treated with metformin (73, 74 ).”
BackgroundPrevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
General and abdominal adiposity and risk of death in Europe
Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M. B., Overvad, K., van der Schouw, Y. T., Spencer, E., Moons, K. G. M., Tjønneland, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801891 · Cited by 2,155
Romero-Corral, A., Montori, V. M., Somers, V. K., Korinek, J., Thomas, R. J., Allison, T. G., Mookadam, F., & Lopez-Jimenez, F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69251-9 · Cited by 1,652
Flagged first, then by citations
2 of the 96 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,001
Implications of obesity across the heart failure continuum
Elagizi, A., Carbone, S., Lavie, C. J., Mehra, M. R., & Ventura, H. O. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.09.005 · Cited by 64
Self-citationKim, S. R., Lee, G., Choi, S., Oh, Y. H., Son, J. S., Park, M., & Park, S. M. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12962 · Cited by 58
Motivational effects of coronary artery calcium scores on statin adherence and weight loss
Kalia, N. K., Cespedes, L., Youssef, G. S., Li, D., & Budoff, M. J. (2014) · Coronary Artery Disease · doi:10.1097/mca.0000000000000207 · Cited by 58
Leptin Signaling in the Failing and Mechanically Unloaded Human Heart
McGaffin, K. R., Moravec, C. S., & McTiernan, C. F. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.869909 · Cited by 59
The obesity paradox in elderly obese patients undergoing coronary artery bypass surgery
Le-Bert, G., Santana, O., Pineda, A. M., Zamora, C., Lamas, G. A., & Lamelas, J. (2011) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2010.256677 · Cited by 58
Examining the Walking Accessibility, Willingness, and Travel Conditions of Residents in Saudi Cities
Rahman, M. T., & Nahiduzzaman, K. M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16040545 · Cited by 58
Lymphatic Function Regulates Contact Hypersensitivity Dermatitis in Obesity
Savetsky, I. L., Albano, N. J., Cuzzone, D. A., Gardenier, J. C., Torrisi, J. S., Nores, G. D. G., Nitti, M. D., Hespe, G. E., Nelson, T. S., Kataru, R. P., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.283 · Cited by 58
Cabassa, L. J., Stefančić, A., O’Hara, K., El‐Bassel, N., Lewis‐Fernández, R., Luchsinger, J. A., Gates, L. B., Younge, R. G., Wall, M. W., Weinstein, L. C., et al. (2015) · Trials · doi:10.1186/s13063-015-0902-z · Cited by 58
Increased Cardiovascular Disease Risk in Veterans With Mental Illness
Vance, M. C., Wiitala, W. L., Sussman, J. B., Pfeiffer, P., & Hayward, R. A. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.005563 · Cited by 57
Özeke, Ö., Özer, C., Güngör, M., Celenk, M. K., Dinçer, H., & Iliçin, G. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.08.030 · Cited by 57
Liu, X., Liu, Y., Zhan, J., & He, Q. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9973-5 · Cited by 57
Hansel, B., Roussel, R., Elbez, Y., Marre, M., Krempf, M., Ikeda, Y., Eagle, K. A., Elisaf, M., Bhatt, D. L., & Steg, P. G. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv347 · Cited by 57
on behalf of the LEADER investigators, Masmiquel, L., Leiter, L. A., Vidal, J., Bain, S. C., Petrie, J. R., Franek, E., Raz, I., Comlekci, A., Jacob, S., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0341-5 · Cited by 60
Pterostilbene, a dimethylated analog of resveratrol, promotes energy metabolism in obese rats
Nagao, K., Jinnouchi, T., Kai, S., & Yanagita, T. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.009 · Cited by 57
Rovella, V., Anemona, L., Cardellini, M., Scimeca, M., Saggini, A., Santeusanio, G., Bonanno, E., Montanaro, M., Legramante, I. M., Ippoliti, A., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0685-0 · Cited by 58
Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity
Karwi, Q. G., Zhang, L., Altamimi, T., Wagg, C. S., Patel, V. B., Uddin, G. M., Joerg, A. R., Padwal, R. S., Johnstone, D. E., Sharma, A. M., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13762 · Cited by 57
Obesity and weight management in the elderly: A focus on men
Han, T. S., Wu, F. C. W., & Lean, M. E. J. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.04.012 · Cited by 57
Heart failure epicardial fat increases atrial arrhythmogenesis
Lin, Y., Chen, Y., Chang, S., Lin, Y., Chen, J.-H., Yeh, Y., Chen, S.-A., & Chen, Y. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.05.009 · Cited by 56
The impact of wait list body mass index changes on the outcome after liver transplantation
Orci, L. A., Majno, P. E., Berney, T., Morel, P., Mentha, G., & Toso, C. (2012) · Transplant International · doi:10.1111/tri.12017 · Cited by 56
Herget, S., Rudolph, A., Hilbert, A., & Blüher, S. (2014) · Obesity Facts · doi:10.1159/000365793 · Cited by 56
Does Vascular Calcification Accelerate Inflammation?
Joshi, F. R., Rajani, N. K., Abt, M., Woodward, M., Bucerius, J. A., Mani, V., Tawakol, A. A., Kallend, D. G., Fayad, Z. A., & Rudd, J. H. F. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.050 · Cited by 56
Pisitsak, C., Lee, J. G. H., Boyd, J. H., Coxson, H. O., Russell, J. A., & Walley, K. R. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001870 · Cited by 56
Joyce, E., Lala, A., Stevens, S. R., Cooper, L. B., AbouEzzeddine, O. F., Groarke, J. D., Grodin, J. L., Braunwald, E., Anstrom, K. J., Redfield, M. M., et al. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.09.013 · Cited by 56
Nagayama, D., Imamura, H., Sato, Y., Yamaguchi, T., Ban, N., Kawana, H., Ohira, M., Saiki, A., Shirai, K., & Tatsuno, I. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s119646 · Cited by 57
Yang, Q., Qi, M., Tong, R., Wang, D., Ding, L., Li, Z., Huang, C., Wang, Z., & Yang, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071393 · Cited by 56
Survival Benefit of Obese Patients With Pulmonary Embolism
Keller, K., Hobohm, L., Münzel, T. F., Ostad, M. A., Espinola–Klein, C., Lavie, C. J., Konstantinides, S., & Lankeit, M. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.04.035 · Cited by 56
Self-citationMalnutrition outweighs the effect of the obesity paradox
Prausmüller, S., Heitzinger, G., Pávó, N., Spinka, G., Goliasch, G., Arfsten, H., Gabler, C., Strunk, G., Hengstenberg, C., Hülsmann, M., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12980 · Cited by 55
Rodrigues, S. L., Baldo, M. P., & Mill, J. G. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010005000073 · Cited by 55
The Obesity Paradox in Stroke: Impact on Mortality and Short-term Readmission
Barba, R., Marco, J., Ruiz, J. R., Canora, J., Hinojosa, J., Plaza, S., & Zapatero, A. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.11.002 · Cited by 55
Sweet tea leaves extract improves leptin resistance in diet-induced obese rats
Zhou, C.-J., Huang, S. M., Liu, J., Qiu, S.-Q., Xie, F.-Y., Song, H.-P., Li, Y., Hou, S., & Lai, X. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.09.057 · Cited by 55
Sibutramine on Cardiovascular Outcome
Scheen, A. J. (2011) · Diabetes Care · doi:10.2337/dc11-s205 · Cited by 55
Long-term survival and fate of the leg in de novo intermittent claudication
Kumakura, H., Kanai, H., Hojo, Y., Iwasaki, T., & Ichikawa, S. (2016) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw057 · Cited by 56
Trends in Obesity and Risk of Cardiovascular Disease
Lahey, R., & Khan, S. S. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0160-1 · Cited by 56
Prognosis of Morbid Obesity Patients With Advanced Heart Failure
Nagarajan, V., Cauthen, C. A., Starling, R. C., & Tang, W. H. W. (2013) · Congestive Heart Failure · doi:10.1111/chf.12038 · Cited by 54
Batsis, J. A., Singh, S., & López-Jiménez, F. A. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0366-3 · Cited by 54
Atashak, S., Peeri, M., Azarbayjani, M. A., Stannard, S. R., & Haghighi, M. M. (2011) · Europe PMC (PubMed Central) · Cited by 54
Kumar, S. A., Magnusson, M. E., Ward, L. C., Paul, N. A., & Brown, L. (2015) · Marine Drugs · doi:10.3390/md13020788 · Cited by 55
Héritier, H., Vienneau, D., Foraster, M., Eze, I. C., Schaffner, E., Thiesse, L., Ruzdik, F., Habermacher, M., Köpfli, M., Pieren, R., et al. (2018) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2018.02.005 · Cited by 54
Pouwels, S., Topal, B., Knook, M. T. T., Çelik, A., Sundbom, M., Ribeiro, R. J. D. S., Parmar, C. D., & Ugale, S. M. (2019) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2019.1581064 · Cited by 54
Mukerji, R., Petruc, M., Fresen, J. L., Terry, B. E., Govindarajan, G., & Alpert, M. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.03.045 · Cited by 54
Ades, P. A., Savage, P. D., Lischke, S., Toth, M. J., Harvey‐Berino, J., Bunn, J. Y., Ludlow, M., & Schneider, D. J. (2011) · CHEST Journal · doi:10.1378/chest.10-3289 · Cited by 53
The Obesity Paradox and Outcome in Heart Failure: Is Excess Bodyweight Truly Protective?
Arena, R. A., & Lavie, C. J. (2009) · Future Cardiology · doi:10.2217/fca.09.158 · Cited by 53
Self-citationSerum Levels of the Adipokine Progranulin Depend on Renal Function
Richter, J., Focke, D., Ebert, T., Kovacs, P. L., Bachmann, A., Lössner, U., Kralisch, S., Kratzsch, J., Beige, J., Anders, M. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0220 · Cited by 53
Adipose tissue and vascular inflammation in coronary artery disease
Golia, E. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i7.539 · Cited by 56
Perivascular Adipose Tissue–Derived PDGF-D Contributes to Aortic Aneurysm Formation During Obesity
Zhang, Z.-B., Ruan, C., Lin, J., Xu, L., Chen, X.-H., Du, Y.-N., Fu, M., Kong, L., Zhu, D., & Gao, P.-J. (2018) · Diabetes · doi:10.2337/db18-0098 · Cited by 54
Fukuoka, S., Kurita, T., Dohi, K., Masuda, J., Seko, T., Tanigawa, T., Saito, Y., Kakimoto, H., Makino, K., & Ito, M. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.011 · Cited by 53
Leptin as a Key between Obesity and Cardiovascular Disease
Kang, K., Ok, M., & Lee, S. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20120 · Cited by 53
Gengxin, Y., Xuehan, M., Xinyu, W., Yali, Y., Yiran, X., Zheng, L., Qiu, Y., Li, G., & Chen, L. (2024) · Age and Ageing · doi:10.1093/ageing/afae286 · Cited by 52
Assessing Personality in theDSM–5: The Utility of Bipolar Constructs
Samuel, D. B. (2011) · Journal of Personality Assessment · doi:10.1080/00223891.2011.577476 · Cited by 54
Bornhoeft, J., Castaneda, D., Nemoseck, T., Wang, P., Henning, S. M., & Hong, M. Y. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2011.0258 · Cited by 52
O’Donnell, D. E., O’Donnell, C. D. J., Webb, K. A., & Guenette, J. A. (2012) · Pulmonary Medicine · doi:10.1155/2012/818925 · Cited by 56
Çolak, Y., Marott, J. L., Vestbo, J., & Lange, P. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.933955 · Cited by 52
Esmailiyan, M., Amerizadeh, A., Vahdat, S., Ghodsi, M., Doewes, R. I., & Sundram, Y. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.101034 · Cited by 54
Ferreira, T. D. S., Klein, M. R. S. T., & Sanjuliani, A. F. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000111 · Cited by 51
Hanai, K., Babazono, T., Nyumura, I., Toya, K., Ohta, M., Bouchi, R., Suzuki, K., Inoue, A., & Iwamoto, Y. (2009) · Clinical and Experimental Nephrology · doi:10.1007/s10157-009-0245-8 · Cited by 52
Adipose tissue in renal disease: clinical significance and prognostic implications
Iglesias, P., & Díez, J. J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq246 · Cited by 51
Mnafgui, K., Hamden, K., Salah, H. B., Kchaou, M., Nasri, M., Slama, S., Derbali, F., Allouche, N., & Elfeki, A. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/620384 · Cited by 51
Haq, Z. U., Mackay, D., Fenwick, E. A. L., & Pell, J. P. (2013) · Psychological Medicine · doi:10.1017/s0033291713002833 · Cited by 51
Giesinger, J. M., Loth, F. L. C., MacDonald, D. J., Giesinger, K., Patton, J. T., Simpson, H., HOWIE, C. R., & Hamilton, D. F. (2018) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-018-4853-2 · Cited by 51
Lin, D., Wang, L., Yan, S., Zhang, Q., Zhang, J. H., & Shao, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2491927 · Cited by 51
Siddiqui, S. Y., Athar, A., Khan, M. A., Abbas, S., Saeed, Y., Khan, M. F., & Hussain, M. (2020) · Journal of Medical Imaging and Health Informatics · doi:10.1166/jmihi.2020.2996 · Cited by 50
Maor, E., Grossman, Y., Balmor, G. R., Segel, M. J., Fefer, P., Ben‐Zekry, S., Buber, J., DiSegni, E., Guetta, V., Ben‐Dov, I., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.198 · Cited by 50
Impact of Body Mass Index on Clinical Outcome in Patients Hospitalized With Congestive Heart Failure
Komukai, K., Minai, K., Arase, S., Ogawa, T., Nakane, T., Nagoshi, T., Kayama, Y., Abe, Y., Morimoto, S., Ogawa, K., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0727 · Cited by 50
Complications Following Colon Rectal Surgery in the Obese Patient
Geiger, T. M., & Muldoon, R. L. (2011) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0031-1295692 · Cited by 50
Thovhogi, N., Sibuyi, N. R. S., Meyer, M., Onani, M. O., & Madiehe, A. M. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-2904-x · Cited by 50
Assessing the genetic overlap between BMI and cognitive function
CHARGE Cognitive Working Group, Marioni, R. E., Yang, J., Dykiert, D., Mõttus, R., Campbell, A., Davies, G., Hayward, C., Porteous, D. J., Visscher, P. M., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.205 · Cited by 50
Sex differences in fat distribution influence the association between BMI and arterial stiffness
van den Munckhof, I., Holewijn, S., Graaf, J. D., & Rutten, J. H. W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001297 · Cited by 50
Impact of Obesity on Ventricular Assist Device Outcomes
Jaiswal, A., Truby, L., Chichra, A., Jain, R., Myers, L., Patel, N., & Topkara, V. K. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.10.001 · Cited by 49
Zern, E. K., Wang, D., Rambarat, P., Bernard, S., Paniagua, S. M., Liu, E. E., McNeill, J., Wang, J. K., Andrews, C. T., Pomerantsev, E. V., et al. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.009085 · Cited by 53
Schutter, A. D., Lavie, C. J., Patel, D. A., & Milani, R. V. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328363bcca · Cited by 49
Self-citationLavie, C. J., Milani, R. V., Patel, D. A., Artham, S. M., & Ventura, H. O. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.05.2011 · Cited by 49
Self-citationVarady, K. A., Bhutani, S., Klempel, M. C., & Phillips, S. A. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-8 · Cited by 49
Beneficial Effects of Bariatric Surgery on Cardiac Structure and Function in Obesity
Shin, S., Lee, Y. J., Heo, Y., Park, S., Kwon, S., Woo, S., Kim, D., Park, K. S., & Kwan, J. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2330-x · Cited by 50
Obesity and Functional Impairment: Influence of Comorbidity, Joint Pain, and Mental Health
Heo, M., Pietrobelli, A., Wang, D., Heymsfield, S. B., & Faith, M. S. (2009) · Obesity · doi:10.1038/oby.2009.400 · Cited by 49
Obesity and Congestive Heart Failure
Steiner, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-49253-7_6 · Cited by 49
Wang, J., Wu, M., Wu, S., & Tian, Y. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13820 · Cited by 49
Pericoronary Adipose Tissue: A Novel Therapeutic Target in Obesity-Related Coronary Atherosclerosis
Mazurek, T., & Opolski, G. (2015) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.933685 · Cited by 48
Obese mice on a high‐fat alternate‐day fasting regimen lose weight and improve glucose tolerance
Joslin, P. M. N., Bell, R. K., & Swoap, S. J. (2016) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12546 · Cited by 50
Wei, Y., Tsai, Y., Wang, C., & Kuo, P. (2017) · International Journal of COPD · doi:10.2147/copd.s138571 · Cited by 48
Li, T., Gao, J., Du, ., Song, J., & Mao, X. (2018) · Nutrients · doi:10.3390/nu10030331 · Cited by 48
Wilding, J. P. H., Zourikian, N., Minno, M. N. D. D., Khair, K., Marquardt, N., Benson, G. M., Ozelo, M. C., & Hermans, C. R. J. R. (2018) · Obesity Reviews · doi:10.1111/obr.12746 · Cited by 49
Man, A. W. C., Xia, N., & Li, H. (2020) · Antioxidants · doi:10.3390/antiox9100968 · Cited by 49
daSilva‐deAbreu, A., Alhafez, B. A., Curbelo-Peña, Y., Lavie, C. J., Ventura, H. O., Loro-Ferrer, J. F., & Mandras, S. A. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.12.011 · Cited by 47
Self-citationImpact of body mass index on mortality in heart failure patients
Takiguchi, M., Yoshihisa, A., Miura, S., Shimizu, T., Nakamura, Y., Yamauchi, H., Iwaya, S., Owada, T., Miyata, M., Abe, S., et al. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12354 · Cited by 49
Obesity Paradox in Different Populations: Evidence and Controversies
Goel, K., López-Jiménez, F. A., Schutter, A. D., Coutinho, T. A., & Lavie, C. J. (2013) · Future Cardiology · doi:10.2217/fca.13.84 · Cited by 47
Self-citationLin, Q., & Yun, Z. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00039 · Cited by 47
Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice
Ferreira, J. P., & Santos, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023133 · Cited by 47
Gupta, A., & Johnson, W. D. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-36 · Cited by 47
Guauque-Olarte, S., Gaudreault, N., Piché, M., Fournier, D., Mauriège, P., Mathieu, P., & Bossé, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019908 · Cited by 48
Gil, E., Na, S. J., Ryu, J.-A., Lee, D.-S., Chung, C. R., Cho, Y. H., Jeon, K., Sung, K., Suh, G. Y., & Yang, J. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176143 · Cited by 47
Strategies used by the Canadian food and beverage industry to influence food and nutrition policies
Vandenbrink, D., Pauzé, E., & Kent, M. P. (2020) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-019-0900-8 · Cited by 47
Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders
Duan, J., Song, Y., Zhang, X., & Wang, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.646491 · Cited by 47
Baeradeh, N., Johari, M. G., Moftakhar, L., Rezaeianzadeh, R., Hosseini, S. V., & Rezaianzadeh, A. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02683-w · Cited by 47
Hemmami, H., Seghir, B. B., Zeghoud, S., Amor, I. B., Kouadri, I., Rebiai, A., Zaater, A., Messaoudi, M., Benchikha, N., SAWICKA, B. H., et al. (2023) · Molecules · doi:10.3390/molecules28041834 · Cited by 46
Schutter, A. D., Lavie, C. J., Patel, D. A., Artham, S. M., & Milani, R. V. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.11.013 · Cited by 46
Self-citationEtiologies, Trends, and Predictors of 30-Day Readmissions in Patients With Diastolic Heart Failure
Arora, S., Lahewala, S., Virk, H. U. H., Setareh‐Shenas, S., Patel, P., Kumar, V. M., Tripathi, B., Shah, H., Patel, V., Gidwani, U. K., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.028 · Cited by 46
The obesity paradox and incident cardiovascular disease: A population-based study
Chang, V. W., Langa, K. M., Weir, D. R., & Iwashyna, T. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188636 · Cited by 46
Fernández‐Jiménez, R., Santos-Beneit, G., Tresserra‐Rimbau, A., Bodega, P., de Miguel, M., de Cos-Gandoy, A., Rodríguez, C., Carral, V., Orrit, X., Haro, D., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.03.014 · Cited by 50
Ganjayi, M. S., Ramesh, G., Prasad, R. D., & Meriga, B. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1740742 · Cited by 46
Brochu, P., Bouchard, M., & Haddad, S. (2013) · Risk Analysis · doi:10.1111/risa.12125 · Cited by 46
Metadata
- Authors
- Lavie, C. J., Milani, R. V., & Ventura, H. O.
- Affiliations
- Ochsner Health System (US)
- Ochsner Medical Center (US)
- Corresponding author
- Lavie, Carl J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 53
- Issue
- 21
- Pages
- 1925-1932
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1598667444
- Cited by
- 2,326
- References
- 96
- Citations by year
- 2026: 87 · 2025: 110 · 2024: 129 · 2023: 107 · 2022: 130 · 2021: 159 · 2020: 162 · 2019: 135 · 2018: 143 · 2017: 141 · 2016: 157 · 2015: 139 · 2014: 152 · 2013: 153 · 2012: 135
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, cardiovascular disease, obesity paradox, heart failure, coronary artery disease, sudden cardiac death, atrial fibrillation, hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular risk factors, weight loss, obesity pathogenesis
- MeSH terms
- Cardiovascular Diseases, Humans, Obesity, Risk Factors, United States, Weight Loss, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
